Campochiaro, Peter A
- Johns Hopkins University · Ophthalmology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #9,802
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2007 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Ophthalmology
NIH Funding · FY2023
Linked Award Amount
$1M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#9,802
By linked amount among FY2023 PIs
Earliest Year Loaded
2007
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Campochiaro, Peter A as a PI. Multi-PI records show the full award amount for context.
- 5R01EY031097-04R01Contact PISuprachoroidal nonviral gene transfer of engineered VEGF antagonistsJohns Hopkins University · Ophthalmology (NIH department code)$598.9Kaward amount
- 5UG1EY033286-02UG1Contact PINAC Attack, A Phase-3, Multicenter, Randomized, Placebo-Controlled Trial in Patents with Retinitis PigmentosaJohns Hopkins University · Ophthalmology (NIH department code)$428Kaward amount
Award organization
Organizations that administered FY2023 awards listing Campochiaro, Peter A as a PI.
FY2023 award administered by Johns Hopkins University (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2007First NIH AwardJohns Hopkins University
- 2007$500K Cumulative Funding
- 2007Entered Top 50% NationallyRanked #7158
- 2008$1M Cumulative Funding
- 2009$2M Cumulative Funding
- 2011$5M Cumulative Funding
- 2011R01 Grant Holder
- 2020Entered Top 25% NationallyRanked #2855
- 2021$10M Cumulative Funding